Iris De Falco, PhD, has a diverse work experience in the field of biomedical engineering. Iris worked at MMI S.p.A. as a Clinical Development Engineer and Medical Affairs, where they collaborated with the R&D&I team and monitored clinical outcomes. Prior to that, they worked as a Clinical Development Engineer at the same company, where they proposed user specifications, product inputs, and test protocols.
Before joining MMI S.p.A., Dr. De Falco worked at MASMEC Biomed - MASMEC SpA division as a Product Specialist. Their responsibilities included training surgeons on navigation systems, providing technical assistance during interventions, and supporting national and international events. Iris also handled the production of technical documentation for FDA system certification.
Dr. De Falco's previous experience includes working as a RAMS Engineer at ResilTech S.r.l., where they provided consultancies and technical support for the design of safe systems, verification and validation, safety analysis, and certification. Iris also worked as a Biomedical Engineer at Scuola Superiore Sant'Anna, The BioRobotics Institute, and as a Visiting Research Fellow at TU Delft. Additionally, they served as a Research Collaborator at CNR-IFC, National Research Council Institute of Clinical Physiology.
Overall, Dr. De Falco's work experience demonstrates their expertise in clinical development, product specialization, technical support, and research collaborations in the field of biomedical engineering.
Iris De Falco, PhD, completed their education in a chronological order. Iris first attended Università di Pisa from 2006 to 2009, earning a Bachelor's degree in Industrial Engineering. Iris then pursued a Master's degree in Industrial Engineering, with a focus on Biomedical Engineering, from the same institution from 2009 to 2011. Iris De Falco furthered their education by attending Scuola Superiore Sant'Anna from 2012 to 2016, where they obtained their Doctor of Philosophy (PhD) degree in Innovative Technologies, specializing in Biorobotics.
May, 2021 - present
December, 2018